Financials

  • Market Capitalization 21.02 M
  • Employee 18
  • Founded 2020
  • CEO N/A
  • Website www.tevogen.com
  • Headquarter Delaware, United States
  • FIGI BBG013395405
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.7
Rapporto prezzo/fatturato
-66.55

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4586
KZIA
Kazia Therapeutics Limited - American Depositary Shares
13.47 USD-0.88%+2.75%-5.80%+130.26%21.81 M USD
4587
SKYE
Skye Bioscience, Inc. - Common Stock
0.62 USD-6.06%-11.43%-11.43%-22.50%21.79 M USD
4597
CLRB
Cellectar Biosciences, Inc. - Common Stock
2.63 USD0.00%-2.59%+11.91%-16.24%21.02 M USD
4612
JSPR
Jasper Therapeutics, Inc. - Class A Common Stock
0.72 USD+18.03%+50.00%+53.19%-78.57%20.16 M USD

Notizie